Company intelligence / Profile preview

Cytokinetics

South San Francisco, California, United Statescytokinetics.com ↗
Ownership
Public · CYTK
Employees
~460
Development stage
Other
01

Overview

Cytokinetics has advanced its lead program aficamten into late-stage clinical trials for hypertrophic cardiomyopathy. The company’s pipeline includes several first-in-class and next-in-class small molecule drugs targeting cardiac and skeletal muscles. Clinical results have shown promise in improving outcomes for patients with heart failure and HCM. The company continues to expand its research into additional indications related to impaired or declining muscle function.

Therapeutic areas
CardiovascularNeurology
Modalities
small molecules
Industry
Biotech
02

Drug pipeline

15 assets

aficamten

Approved

14 more assets in the full pipeline.

03

Partnerships

Astellas Pharma (licensing/discovery deal for treatments of muscle weakness/fatigue)Ji Xing Pharmaceuticals (commercialization rights for aficamten in China/Asia regions)
04

Financials

Market cap
$7.7B
Total revenue
$88M
Enterprise value
$7.9B

Beyond the preview

Go deeper on Cytokinetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokinetics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call